These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A. Beske PH; Hoffman KM; Machamer JB; Eisen MR; McNutt PM Sci Rep; 2017 Nov; 7(1):15862. PubMed ID: 29158500 [TBL] [Abstract][Full Text] [Related]
6. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism. Simpson LL Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675 [TBL] [Abstract][Full Text] [Related]
7. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F. Siegel LS; Johnson-Winegar AD; Sellin LC Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule. Mayorov AV; Willis B; Di Mola A; Adler D; Borgia J; Jackson O; Wang J; Luo Y; Tang L; Knapp RJ; Natarajan C; Goodnough MC; Zilberberg N; Simpson LL; Janda KD ACS Chem Biol; 2010 Dec; 5(12):1183-91. PubMed ID: 20936877 [TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism. Siegel LS; Price JI Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299 [TBL] [Abstract][Full Text] [Related]
10. Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations. Adler M; Deshpande SS; Apland JP; Murray B; Borrell A Neurochem Int; 2012 Nov; 61(6):866-73. PubMed ID: 22841859 [TBL] [Abstract][Full Text] [Related]
11. Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization. Zakhari JS; Kinoyama I; Hixon MS; Di Mola A; Globisch D; Janda KD Bioorg Med Chem; 2011 Nov; 19(21):6203-9. PubMed ID: 21975066 [TBL] [Abstract][Full Text] [Related]
12. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps. Adler M; Capacio B; Deshpande SS Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273 [TBL] [Abstract][Full Text] [Related]
13. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin. Adler M; Macdonald DA; Sellin LC; Parker GW Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations. Adler M; Scovill J; Parker G; Lebeda FJ; Piotrowski J; Deshpande SS Toxicon; 1995 Apr; 33(4):527-37. PubMed ID: 7570638 [TBL] [Abstract][Full Text] [Related]
15. 3,4-Diaminopyridine reverses respiratory paralysis induced by a presynaptically active snake venom and its major neurotoxin. Watt G; Smith CD; Kaewsupo A; Davis TM Trans R Soc Trop Med Hyg; 1994; 88(2):243-6. PubMed ID: 8036689 [TBL] [Abstract][Full Text] [Related]
16. Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model. Torgeman A; Schwartz A; Diamant E; Baruchi T; Dor E; Ben David A; Pass A; Barnea A; Tal A; Rosner A; Rosen O; Zichel R Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115749 [TBL] [Abstract][Full Text] [Related]
17. Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature. Eser F; Hasanoğlu İ; Kayaaslan B; Kaya Kalem A; Bilen Ş; Orhan G; Güner R J Infect Dev Ctries; 2024 Mar; 18(3):480-487. PubMed ID: 38635607 [TBL] [Abstract][Full Text] [Related]
19. A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism. Torgeman A; Diamant E; Dor E; Schwartz A; Baruchi T; Ben David A; Zichel R Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678971 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril? Karcioglu O; Akman C; Atnis I Curr Pharm Des; 2024; 30(8):578-588. PubMed ID: 38409723 [No Abstract] [Full Text] [Related] [Next] [New Search]